Sinopharm
1099.HK
#2291
Rank
S$10.59 B
Marketcap
S$3.39
Share price
-0.39%
Change (1 day)
-0.27%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2024: S$2.95 Billion

According to Sinopharm's latest financial reports the company's current earnings are S$80.09 Billion. In 2024 the company made an earning of S$2.95 Billion a decrease over its 2023 earnings that were of S$4.09 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2024

Annual earnings

Year Earnings Change
2024S$2.95 B-27.86%
2023S$4.09 B-0.73%
2022S$4.12 B-1.72%
2021S$4.19 B11.7%
2020S$3.75 B18.44%
2019S$3.17 B10.85%
2018S$2.85 B3.05%
2017S$2.77 B36.48%
2016S$2.03 B7.11%
2015S$1.89 B12.38%
2014S$1.68 B25.05%
2013S$1.35 B22.54%
2012S$1.10 B35.43%
2011S$0.81 B52.24%
2010S$0.53 B30.99%
2009S$0.40 B60.59%
2008S$0.25 B48.29%
2007S$0.17 B123.29%
2006S$76.77 M